Actavis (Now Allergan)

Actavis (Now Allergan) company information, Employees & Contact Information

Updated May 2026

Quick answer

Actavis (Now Allergan) is a Pharmaceutical Manufacturing company and founded in 1984. It has approximately 1,346 employees on record. Contact data was last refreshed in May 2026. Find Actavis (Now Allergan)'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Actavis (Now Allergan) email format Actavis (Now Allergan) management contacts

Related company profiles:

We would like to invite you to follow our new Allergan page at https://www.linkedin.com/company/allergan?trk=top_nav_home

Company Details

Employees
1.35K
Founded
-
Address
1 Grand Canal Square, Docklands,united States
Phone
1(800) 900-1644
Email
te****@****arm.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
actavis.com
Keywords
Generic Pharmaceuticals, Branded Pharmaceuticals, Over-the-Counter Pharmaceuticals, Biologics.
HQ
Dublin
Competitors
Allergan Aesthetics, an AbbVie Company, Galderma, Actavis plc (now Allergan), Allergan, AbbVie, Teva Pharmaceuticals, Sanofi, GSK, Pfizer, SkinMedica®.
Looking for a particular Actavis (Now Allergan) employee's phone or email?

Actavis (Now Allergan) Questions

News

Actavis Completes Acquisition of Auden Mckenzie - PR Newswire

Actavis Completes Acquisition of Auden Mckenzie PR Newswire

Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue - MultiVu

Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue MultiVu

425 - SEC.gov

425 SEC.gov

Actavis And Perrigo Receive FDA Approval Of Guaifenesin/Pseudoephedrine, The Store Brand Equivalent To Mucinex® D Tablets - PR Newswire

Actavis And Perrigo Receive FDA Approval Of Guaifenesin/Pseudoephedrine, The Store Brand Equivalent To Mucinex® D Tablets PR Newswire

Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults - PR Newswire

Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults PR Newswire

Actavis Launches Generic Version of Intuniv® - PR Newswire

Actavis Launches Generic Version of Intuniv® PR Newswire

Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer - PR Newswire

Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer PR Newswire

Actavis Receives Final Approval for Generic Version of Subutex® - PR Newswire

Actavis Receives Final Approval for Generic Version of Subutex® PR Newswire

Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition - PR Newswire

Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition PR Newswire

Actavis Confirms Generic Quillivant XR® Patent Challenge - PR Newswire

Actavis Confirms Generic Quillivant XR® Patent Challenge PR Newswire

Actavis Receives FDA Approval of SAPHRIS® for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder - PR Newswire

Actavis Receives FDA Approval of SAPHRIS® for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder PR Newswire

Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company - PR Newswire

Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company PR Newswire

Actavis Completes Allergan Acquisition - PR Newswire

Actavis Completes Allergan Acquisition PR Newswire

Actavis Announces Tentative Agreement Related to Asacol® HD Patent Challenge Litigation - PR Newswire

Actavis Announces Tentative Agreement Related to Asacol® HD Patent Challenge Litigation PR Newswire

Actavis Completes Forest Laboratories Acquisition - PR Newswire

Actavis Completes Forest Laboratories Acquisition PR Newswire

Actavis and Medicines360 Announce FDA Approval of LILETTA™ (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years - PR Newswire

Actavis and Medicines360 Announce FDA Approval of LILETTA™ (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years PR Newswire

Actavis' Generic Version of Micardis® Receives FDA Approval - PR Newswire

Actavis' Generic Version of Micardis® Receives FDA Approval PR Newswire

Actavis and Adamas Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride - PR Newswire

Actavis and Adamas Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride PR Newswire

Actavis Receives U.S. FDA Approval for AVYCAZ™ (CEFTAZIDIME-AVIBACTAM) - PR Newswire

Actavis Receives U.S. FDA Approval for AVYCAZ™ (CEFTAZIDIME-AVIBACTAM) PR Newswire

Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries - PR Newswire

Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries PR Newswire

Actavis Launches NAMZARIC™ (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease - PR Newswire

Actavis Launches NAMZARIC™ (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease PR Newswire

Actavis Completes Acquisition of Furiex Pharmaceuticals - PR Newswire

Actavis Completes Acquisition of Furiex Pharmaceuticals PR Newswire

Generic Temovate Launched by Actavis - Medical Professionals Reference

Generic Temovate Launched by Actavis Medical Professionals Reference

Actavis To Present At The Goldman Sachs Conference; Webcast At 12:00 PM ET - RTTNews

Actavis To Present At The Goldman Sachs Conference; Webcast At 12:00 PM ET RTTNews

Actavis Receives FDA Approval for VIIBRYD® (vilazodone HCl) 20mg Once Daily as a Therapeutic Dose - PR Newswire

Actavis Receives FDA Approval for VIIBRYD® (vilazodone HCl) 20mg Once Daily as a Therapeutic Dose PR Newswire

Actavis Extends Exclusive Agreement to Distribute Authorized Generic Concerta® - PR Newswire

Actavis Extends Exclusive Agreement to Distribute Authorized Generic Concerta® PR Newswire

Actavis Completes Warner Chilcott Acquisition - PR Newswire

Actavis Completes Warner Chilcott Acquisition PR Newswire

Actavis To Present At Bank Of America Conference ; Webcast At 11:40 AM ET - RTTNews

Actavis To Present At Bank Of America Conference ; Webcast At 11:40 AM ET RTTNews

Actavis to Acquire Durata Therapeutics, Inc. - PR Newswire

Actavis to Acquire Durata Therapeutics, Inc. PR Newswire

Actavis Launches Generic Lidoderm® - PR Newswire

Actavis Launches Generic Lidoderm® PR Newswire

Actavis Confirms Generic AndroGel® 1.62% Patent Challenge - PR Newswire

Actavis Confirms Generic AndroGel® 1.62% Patent Challenge PR Newswire

Watson Pharmaceuticals, Inc. is Now Actavis, Inc. - PR Newswire

Watson Pharmaceuticals, Inc. is Now Actavis, Inc. PR Newswire

VIBERZI™ (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine - PR Newswire

VIBERZI™ (eluxadoline) Phase III Trial Results Published in The New England Journal of Medicine PR Newswire

Actavis Approved for Generic Subutex - Medical Professionals Reference

Actavis Approved for Generic Subutex Medical Professionals Reference

Letter to Stakeholders: Pfizer 2015 Annual Review - Pfizer

Letter to Stakeholders: Pfizer 2015 Annual Review Pfizer

Allergan Issues Voluntary Nationwide Recall in the U.S. of Specific Lots of REFRESH® Lacri-Lube®, REFRESH P.M. ®, FML® (fluorometholone ophthalmic ointment) 0.1%, and Blephamide® (sulfacetamide sodium and prednisolone acetate ophthalmic ointm - PR Newswire

Allergan Issues Voluntary Nationwide Recall in the U.S. of Specific Lots of REFRESH® Lacri-Lube®, REFRESH P.M. ®, FML® (fluorometholone ophthalmic ointment) 0.1%, and Blephamide® (sulfacetamide sodium and prednisolone acetate ophthalmic ointm PR Newswire

Investments and Management Moves - communitynews.org

Investments and Management Moves communitynews.org

Actavis CEO steps down - IceNews - Daily News

Actavis CEO steps down IceNews - Daily News

CMA alleges anti-competitive agreements for hydrocortisone tablets - GOV.UK

CMA alleges anti-competitive agreements for hydrocortisone tablets GOV.UK

Actavis pharmaceuticals unaffected by Iceland crisis - IceNews - Daily News

Actavis pharmaceuticals unaffected by Iceland crisis IceNews - Daily News

Actavis to launch first ever OTC oral antibiotic in UK - PressPort

Actavis to launch first ever OTC oral antibiotic in UK PressPort

Companies like Actavis (Now Allergan)

Teva Pharmaceuticals logo - Similar company to Actavis (Now Allergan)

Teva Pharmaceuticals

29.77K
Pfizer logo - Similar company to Actavis (Now Allergan)

Pfizer

100.69K
Allergan logo - Similar company to Actavis (Now Allergan)

Allergan

10.48K
Actavis plc (now Allergan) logo - Similar company to Actavis (Now Allergan)

Actavis Plc (Now All...

NA
Galderma logo - Similar company to Actavis (Now Allergan)

Galderma

8.13K
AbbVie logo - Similar company to Actavis (Now Allergan)

Abbvie

57.01K
GSK logo - Similar company to Actavis (Now Allergan)

Gsk

90.45K
Sanofi logo - Similar company to Actavis (Now Allergan)

Sanofi

88.33K
SkinMedica® logo - Similar company to Actavis (Now Allergan)

Skinmedica®

100
Allergan Aesthetics, an AbbVie Company logo - Similar company to Actavis (Now Allergan)

Allergan Aesthetics,...

2.15K

Top Actavis (Now Allergan) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant